SCHEMBL25098352

SCHEMBL25098352

O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO)C(O)C1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 4/20 0.59
ADORA2A P29274 2/20 0.59
ADORA1 P30542 2/20 0.59
PDE2A O00408 1/20 0.59
ADRA1A P35348 1/20 0.59
PDE4D Q08499 1/20 0.59
PDE3A Q14432 1/20 0.59
P2RX3 P56373 1/20 0.57
PAX8 Q06710 1/20 0.56
MAPK1 P28482 2/20 0.55
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
ALB P02768 1/20 0.55
HPGD P15428 1/20 0.54
TYMP P19971 2/20 0.54
GSK3A P49840 2/20 0.52
RPS6KA3 P51812 2/20 0.52
MAPK14 Q16539 2/20 0.52
DPP4 P27487 1/20 0.51
MEN1 O00255 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9132895 1.00 ADORA3 (0.59) ADORA3ADORA2AADORA1PDE2AADRA1A
SCHEMBL8629175 1.00 ADORA3 (0.59) ADORA3ADORA2AADORA1PDE2AADRA1A
SCHEMBL22883167 0.91 P2RX3 (0.59) ADORA3ADORA2AADORA1PDE2AADRA1A
SCHEMBL23786487 0.90 P2RX3 (0.56) ADORA3ADORA2AADORA1PDE2AADRA1A
Inosine SCHEMBL13320592 0.90 PAX8 (0.69) ADORA3ADORA2AADORA1P2RX3PAX8
Inosine SCHEMBL6933022 0.90 PAX8 (0.69) ADORA3ADORA2AADORA1P2RX3PAX8
Inosine SCHEMBL12964365 0.90 PAX8 (0.69) ADORA3ADORA2AADORA1P2RX3PAX8
Inosine SCHEMBL10001664 0.90 PAX8 (0.69) ADORA3ADORA2AADORA1P2RX3PAX8
Inosine SCHEMBL13012212 0.90 PAX8 (0.69) ADORA3ADORA2AADORA1P2RX3PAX8
Inosine SCHEMBL1738548 0.90 PAX8 (0.69) ADORA3ADORA2AADORA1P2RX3PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022155418-A9 MODIFIED OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2023-03-09 WO disclosed